STOCK TITAN

Saba Capital (IHD) discloses 7.36% stake and backs independent trustee

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D/A

Rhea-AI Filing Summary

Saba Capital Management and related reporting persons filed Amendment No. 5 to their Schedule 13D on Voya Emerging Markets High Dividend Equity Fund. They report beneficial ownership of 1,305,586 common shares, representing 7.36% of the fund’s 17,735,861 shares outstanding as of 2/28/26.

The filing states approximately $7,534,686 was paid to acquire these shares using investor subscription proceeds, capital appreciation, and ordinary-course margin borrowings. On May 6, 2026, a Saba-advised fund notified the issuer of its intention to nominate Paul Kazarian as an independent trustee candidate at the fund’s 2026 annual shareholder meeting.

Positive

  • None.

Negative

  • None.

Insights

Saba discloses a 7.36% stake and proposes an independent trustee for IHD.

The reporting group, led by Saba Capital Management and Boaz Weinstein, holds 1,305,586 common shares of Voya Emerging Markets High Dividend Equity Fund, equal to 7.36% of shares outstanding as of 2/28/26. The aggregate purchase cost is about $7,534,686.

The filing highlights that Saba-accompanied funds financed purchases through investor capital, appreciation, and standard margin borrowings, with positions in margin accounts pledged as collateral. No share transactions occurred in the past sixty days, suggesting the current stake has been stable recently.

An important development is Saba Capital Master Fund, Ltd. notifying the fund on May 6, 2026 of its intention to nominate Paul Kazarian as an independent trustee candidate at the 2026 annual meeting. This step signals an active role in fund governance, with any impact depending on shareholder voting outcomes and the fund’s response.

Beneficial ownership 1,305,586 shares Common shares of IHD reported as beneficially owned
Ownership percentage 7.36% Portion of IHD common shares outstanding as of 2/28/26
Shares outstanding 17,735,861 shares IHD common shares outstanding as of 2/28/26 from N-CSR
Total purchase cost $7,534,686 Approximate amount paid to acquire reported IHD shares
Schedule 13D amendment number Amendment No. 5 Latest amendment to Saba’s 13D on IHD
Event date 05/06/2026 Date of event requiring the Schedule 13D/A filing
Schedule 13D/A regulatory
"This Amendment No. 5 amends Items 3, 4, and 5."
A Schedule 13D/A is an amended disclosure filed with regulators by an investor who already reported owning more than 5% of a company’s shares and needs to update their original filing. Think of it as a public status update that tells markets whether the investor’s ownership, plans, or source of funds have changed; such updates matter because they can signal a push for control, major strategic moves, or increased pressure on management, which can affect stock prices.
beneficial owner regulatory
"the beneficial owner of the Common Shares reported herein."
A beneficial owner is the person who ultimately owns or controls a financial asset or property, even if their name isn't directly on official documents. Think of it like someone who secretly holds the keys to a safe deposit box—others may appear to have access, but the true owner is the one who benefits from what's inside. Identifying beneficial owners helps ensure transparency and prevent illegal activities like money laundering or fraud.
margin account borrowings financial
"and margin account borrowings made in the ordinary course of business."
independent trustee candidate financial
"its intention to nominate Paul Kazarian as an independent trustee candidate"
N-CSR regulatory
"as disclosed in the company's N-CSR filed 5/6/26."
A Form N-CSR is a regulatory filing that mutual funds and other registered investment companies send to the U.S. Securities and Exchange Commission and make available to shareholders; it includes the fund’s certified shareholder report with audited financial statements, performance data and management discussion. For investors, it’s like a fund’s official report card and financial statement combined — it helps you verify how the fund is performing, what risks and fees exist, and whether the manager’s explanations match the numbers.





92912P108

(CUSIP Number)
Saba Capital Management, L.P.
405 Lexington Avenue, 58th Floor, Attention: Michael D'Angelo
New York, NY, 10174
(212) 542-4635

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
05/06/2026

(Date of Event Which Requires Filing of This Statement)


If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).




schemaVersion:


SCHEDULE 13D




Comment for Type of Reporting Person:
The percentages used herein are calculated based upon 17,735,861 shares of common stock outstanding as of 2/28/26, as disclosed in the company's N-CSR filed 5/6/26.


SCHEDULE 13D




Comment for Type of Reporting Person:
The percentages used herein are calculated based upon 17,735,861 shares of common stock outstanding as of 2/28/26, as disclosed in the company's N-CSR filed 5/6/26.


SCHEDULE 13D




Comment for Type of Reporting Person:
The percentages used herein are calculated based upon 17,735,861 shares of common stock outstanding as of 2/28/26, as disclosed in the company's N-CSR filed 5/6/26.


SCHEDULE 13D


Saba Capital Management, L.P.
Signature:/s/ Michael D'Angelo
Name/Title:General Counsel
Date:05/07/2026
Boaz R. Weinstein
Signature:/s/ Michael D'Angelo
Name/Title:Authorized Signatory
Date:05/07/2026
Saba Capital Management GP, LLC
Signature:/s/ Michael D'Angelo
Name/Title:Attorney-in-fact*
Date:05/07/2026
Comments accompanying signature:
Pursuant to a power of attorney dated as of November 16, 2015, which is incorporated herein by reference to Exhibit 2 to the Schedule 13G filed by the Reporting Persons on December 28, 2015, accession number: 0001062993-15-006823

FAQ

What ownership stake does Saba Capital report in Voya Emerging Markets High Dividend Equity Fund (IHD)?

Saba Capital and related reporting persons report beneficial ownership of 1,305,586 common shares of IHD, representing 7.36% of the fund’s outstanding shares. This percentage is based on 17,735,861 shares outstanding as of February 28, 2026, per the fund’s N-CSR filing.

How much did Saba Capital pay to acquire its IHD shares?

The filing states that Saba-related funds paid a total of approximately $7,534,686 to acquire the IHD common shares reported. Funds came from investor subscription proceeds, capital appreciation, and ordinary-course margin account borrowings secured by positions in those accounts.

What governance action is Saba taking at Voya Emerging Markets High Dividend Equity Fund (IHD)?

On May 6, 2026, a Saba-advised fund notified IHD of its intention to nominate Paul Kazarian as an independent trustee candidate for election to the board at the fund’s 2026 annual meeting of shareholders, indicating an active stance on fund governance.

How is Saba Capital’s percentage ownership in IHD calculated in this filing?

The reported 7.36% ownership is calculated using 17,735,861 IHD common shares outstanding as of February 28, 2026. That outstanding share figure is taken from the fund’s N-CSR filed on May 6, 2026, as referenced in the Schedule 13D/A.

Who are the reporting persons in the IHD Schedule 13D/A Amendment No. 5?

The joint filers are Saba Capital Management, L.P., Saba Capital Management GP, LLC, and Boaz R. Weinstein. They share voting and dispositive power over 1,305,586 IHD common shares but indicate the filing is not an admission of beneficial ownership for all purposes.